{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/0185cea5-9e3b-4b82-a887-26f91f92765f/6a88435ee96a6b6c19fb8d6b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f3b71a8cbe675f3cedcb/1787314979785-9b352e13-e046-4cd3-8ade-c3fc3a90da67.jpeg?height=200","description":"<p><strong><em>Nature </em>staff discuss how an FDA-approved drug for narcolepsy could have promise beyond the condition, and the longest-lived human brain organoids yet.</strong></p><p><br></p><p>00:28 The promise of a new narcolepsy drug</p><p><em>Nature: </em><a href=\"#\" rel=\"noopener noreferrer\" target=\"_blank\"><em>First-of-its-kind narcolepsy drug opens door to new therapies for the brain</em></a></p><p><br></p><p>05:53 Human brain organoids kept alive for over five years</p><p><em>Nature: </em><a href=\"#\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Human organoids that mimic brain development grown for years in lab</em></a>​​​​​​​</p><p><br></p><p><a href=\"#\" rel=\"noopener noreferrer\" target=\"_blank\"><strong><em>Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.</em></strong></a></p>","author_name":"Springer Nature Limited"}